|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 201.93 USD | -0.27% |
|
-2.41% | +39.63% |
Chart calendar Johnson & Johnson
Upcoming events on Johnson & Johnson
| 2026-01-20 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-20 | Q4 2025 Earnings Call | Add to your calendar Google Apple ICS format |
| 2026-04-20 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-07-21 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-10-19 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-01-25 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Johnson & Johnson
| 2025-12-05 | American Society of Hematology Meeting - Oral #568 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #5200 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #5199 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #3301 |
| 2025-12-05 | American Society of Hematology Meeting - Plenary Scientific Session Abstract #1 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #4569 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #3934 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #4054 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #4042 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #5821 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #2282 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #701 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #698 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #372 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #691 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #97 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #92 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #94 |
| 2025-12-03 | Citi Global Healthcare Conference |
| 2025-11-24 | Ex-dividend day |
Past dividends on Johnson & Johnson
| 2025-11-24 | Quarterly 1.3 USD |
| 2025-08-25 | Quarterly 1.3 USD |
| 2025-05-26 | Quarterly 1.3 USD |
| 2025-02-17 | Quarterly 1.24 USD |
| 2024-11-25 | Quarterly 1.24 USD |
| 2024-08-26 | Quarterly 1.24 USD |
| 2024-05-19 | Quarterly 1.24 USD |
| 2024-02-15 | Quarterly 1.19 USD |
| 2023-11-19 | Quarterly 1.19 USD |
| 2023-08-24 | Quarterly 1.19 USD |
| 2023-05-21 | Quarterly 1.19 USD |
| 2023-02-16 | Quarterly 1.13 USD |
| 2022-11-20 | Quarterly 1.13 USD |
| 2022-08-21 | Quarterly 1.13 USD |
| 2022-05-22 | Quarterly 1.13 USD |
| 2022-02-17 | Quarterly 1.06 USD |
| 2021-11-21 | Quarterly 1.06 USD |
| 2021-08-22 | Quarterly 1.06 USD |
| 2021-05-23 | Quarterly 1.06 USD |
| 2021-02-21 | Quarterly 1.01 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 94 943 95 017 -0.08% | 85 159 84 764 0.47% | 88 821 88 765 0.06% | 93 750 | 98 436 | 103 327 |
|
EBITDA Million USD | Released Forecast Spread | 32 630 32 564 0.2% | 30 414 31 998 -4.95% | 29 288 30 409 -3.69% | 33 870 | 35 884 | 37 734 |
|
EBIT Million USD | Released Forecast Spread | 29 965 29 608 1.21% | 27 460 27 881 -1.51% | 26 466 26 967 -1.86% | 30 870 | 32 831 | 35 173 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 21 725 25 756 -15.65% | 15 062 20 454 -26.36% | 16 687 20 759 -19.61% | 28 734 | 27 035 | 28 570 |
|
Net income Million USD | Released Forecast Spread | 17 941 20 668 -13.19% | 35 153 19 696 78.48% | 14 066 17 495 -19.6% | 24 777 | 22 400 | 23 371 |
|
EPS USD | Released Forecast Spread | 6,73 7,95 -15.29% | 13,7 8,44 62.56% | 5,79 6,93 -16.39% | 10,5 | 9,50 | 10,1 |
| Announcement Date | 24/01/23 | 23/01/24 | 22/01/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21 383 21 386 -0.01% | 22 447 22 337 0.49% | 22 471 22 171 1.35% | 22 520 22 436 0.38% | 21 893 21 562 1.54% | 23 743 22 861 3.86% | 23 993 23 755 1% | 24 138 | 22 990 | 24 809 | 25 149 | 25 567 | 23 466 | 25 714 | 26 353 |
|
EBITDA Million USD | Released Forecast Spread | 7 973 7 747 2.92% | 8 388 8 129 3.18% | 7 164 7 063 1.43% | 5 763 6 223 -7.4% | 8 037 8 385 -4.15% | 8 637 8 279 4.32% | 8 897 8 583 3.65% | 8 104 | 8 438 | 8 991 | 9 172 | 8 715 | 8 884 | 9 749 | 10 072 |
|
EBIT Million USD | Released Forecast Spread | 7 236 7 203 0.46% | 7 712 7 433 3.76% | 6 489 6 085 6.63% | 5 029 5 471 -8.08% | 7 385 7 290 1.31% | 7 961 7 605 4.68% | 8 168 7 998 2.13% | 7 347 | 7 819 | 8 324 | 8 545 | 7 848 | 8 165 | 8 894 | 9 030 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 440 6 329 1.75% | 5 748 6 910 -16.82% | 3 338 4 923 -32.2% | 3 887 4 591 -15.33% | 13 631 5 447 150.25% | 6 491 6 600 -1.65% | 7 493 6 441 16.34% | 6 208 | 6 750 | 7 306 | 7 502 | 6 706 | |||
|
Net income Million USD | Released Forecast Spread | 5 354 5 293 1.15% | 4 686 5 093 -8% | 2 694 4 083 -34.02% | 3 431 4 240 -19.08% | 10 999 5 229 110.34% | 5 537 5 262 5.23% | 5 152 5 809 -11.3% | 5 241 | 5 677 | 6 175 | 6 255 | 5 499 | |||
|
EPS USD | Released Forecast Spread | 2,20 2,21 -0.57% | 1,93 2,09 -7.72% | 1,11 1,69 -34.13% | 1,41 1,78 -20.69% | 4,54 2,26 100.92% | 2,29 2,18 5.05% | 2,12 2,29 -7.22% | 2,16 | 2,37 | 2,54 | 2,57 | 2,39 | 2,53 | 2,73 | 2,71 |
| Announcement Date | 16/04/24 | 17/07/24 | 15/10/24 | 22/01/25 | 15/04/25 | 16/07/25 | 14/10/25 | - | - | - | - | - | - | - | - |
| 2025-12-08 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-05 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-11 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-15 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-20 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-01-20 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-21 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-01-22 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Johnson & Johnson
| 2025-12-05 | November 2025 Sales and Revenue Release | |
| 2025-11-30 | Q3 2025 Earnings Release | |
| 2025-11-27 | Q2 2026 Earnings Release | |
| 2025-11-19 | Q3 2025 Earnings Release | |
| 2025-11-14 | Q2 2026 Earnings Release | |
| 2025-11-14 | Q2 2026 Earnings Release | |
| 2025-11-14 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release | |
| 2025-11-13 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
- Calendar Johnson & Johnson
Select your edition
All financial news and data tailored to specific country editions
















